Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
Maryam Movassaghian(Harvard University), Amir T. Fathi(Harvard University), Andrew M. Brunner(Harvard University), Hossein Sadrzadeh(Boston University), Karen K. Ballen(University of Virginia Health System), Traci M. Blonquist(Harvard University), Ashley Perry(Harvard University), Eyal C. Attar(Memorial Sloan Kettering Cancer Center), Donna Neuberg(Otsuka (Japan)), Ashmeet Bhatia(Harvard University), Philip C. Amrein(Massachusetts General Hospital)
Cited by 95
Related Papers
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
|Science|2017|1.6k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k